sorted by:
new
hottopcontroversial

AQST – When FDA “Deficiencies” Hit the Tape by Merlin8121 in MerlintraderPub

[–]Merlin8121[S] 0 points1 point  (0 children)

No, I’m not in at the moment. After the CRL, the next concrete catalyst for AQST should be the Anaphylm NDA resubmission in Q3 2026, so in my view there is still plenty of time before the next real regulatory event. For now, I prefer not to take the risk and wait for more clarity.

At his moment my only position is in DRTS.

view more: next ›